IR2-2

Eligibility Conditions for Infected Persons

Infected Blood Inquiry · Second Interim Report · Issued 5 April 2023 · Addressed to: UK Government

Government responseUK Government: Accepted (May 2025)

DeliveryNo statement from UK Government found

Recommendation, verbatim from the inquiry

●Inquiry recommendation

I recommend that the conditions of eligibility for admission of relevant infected persons to the scheme should be that: a) they have been diagnosed as being infected with one or more of HCV (including natural clearers who have suffered loss), HIV, or HBV (limited to chronic cases of HBV unless the infection has resulted in a fatality in the acute period); b) they received a transfusion of blood or components of blood, blood products or transfer of tissue capable of transmitting one or more of the relevant diseases; and c) their infection was not unlikely to have been caused by administration of the relevant treatment, regard being had as to the available evidence as to the measures in place at the time to reduce the possibility of infection, including but not limited to the date of relevant effective screening tests or effective viral inactivation treatments; or d)(i) it was not unlikely to have been caused by transmission to them by a person who fulfils conditions (a) to (c) above, or (ii) by transmission to them by a person who fulfils condition (d)(i), such as a child or children infected by their mother who had previously been infected by her partner, who in turn had been infected as in (a)-(c).

Infected Blood Inquiry, Second Interim Report · 5 Apr 2023 Source PDF →

Published evidence summary

AI-generated evidence summary

In May 2025, the UK Government confirmed that it accepts the recommendation and is compensating individuals directly or indirectly infected through NHS blood, blood products, or tissue (Cabinet Office response, May 2025). It stated in May 2025 that eligible recipients include living or deceased individuals with HIV, Hepatitis C, or chronic Hepatitis B, those indirectly infected through loved ones, and people who died from acute Hepatitis B (Cabinet Office response, May 2025). The record holds no update since the UK Government's response of May 2025 (Cabinet Office response, May 2025).

Sources

AI-generated summary of the record on this page, checked by a second model and automatic checks, 26 Sep 2026.

Government response

●UK Government · Accepted · 14 May 2025

Words of: UK Government, Full Government Response to the Infected Blood Inquiry's May 2024 Report (CP 1318), presented to Parliament by the Minister for the Cabinet Office, 14 May 2025

In accordance with recommendations 1 and 2 of the Second Interim Report, the Government is clear that both those who have been infected and affected by this scandal are eligible for compensation and is compensating those who have been directly or indirectly infected through NHS blood, blood products or tissue. This includes anyone, living or deceased, who has been infected with HIV, Hepatitis C and chronic Hepatitis B, including those who were indirectly infected through their partners or loved ones. Those with acute Hepatitis B infections and have died from their infection during the acute period, are also eligible under the Scheme. Regarding the affected; partners, parents, children, siblings and carers will all be eligible for compensation (subject to certain criteria).

Extract from: Full Government Response to the Infected Blood Inquiry's May 2024 Report

Delivery

No statement on delivery from UK Government has been found in the sources searched. This is separate from the response above.

How this page is built

The recommendation and the government responses are verbatim from primary documents. Delivery statements and other bodies' findings are shown in their own words, each with its source. The summary is written by this site and labelled as such. The Index does not paraphrase sources or characterise intent; it records what has been published.